Drug
Investigational Product 2
Investigational Product 2 is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
67%
Ph not_applicable
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
not_yet_recruiting133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_1
Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women
NCT07529249
completednot_applicable
The Effect of 12-week Dietary Intake of Food Supplements Containing Collagen on Dermis Density and Other Skin Parameters
NCT04988412
completedphase_1
Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels.
NCT01028274
Clinical Trials (3)
Showing 3 of 3 trials
NCT07529249Phase 1
Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women
NCT04988412Not Applicable
The Effect of 12-week Dietary Intake of Food Supplements Containing Collagen on Dermis Density and Other Skin Parameters
NCT01028274Phase 1
Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels.
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3